Coherus BioSciences (FRA:8C5) Days Payable : 222.40 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Coherus BioSciences Days Payable?

Coherus BioSciences's average Accounts Payable for the three months ended in Sep. 2024 was €45.5 Mil. Coherus BioSciences's Cost of Goods Sold for the three months ended in Sep. 2024 was €18.7 Mil. Hence, Coherus BioSciences's Days Payable for the three months ended in Sep. 2024 was 222.40.

The historical rank and industry rank for Coherus BioSciences's Days Payable or its related term are showing as below:

FRA:8C5' s Days Payable Range Over the Past 10 Years
Min: 53.66 Med: 99.38 Max: 441.12
Current: 90.81

During the past 12 years, Coherus BioSciences's highest Days Payable was 441.12. The lowest was 53.66. And the median was 99.38.

FRA:8C5's Days Payable is ranked worse than
58.82% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs FRA:8C5: 90.81

Coherus BioSciences's Days Payable increased from Sep. 2023 (91.99) to Sep. 2024 (222.40). It may suggest that Coherus BioSciences delayed paying its suppliers.

Coherus BioSciences Days Payable Historical Data

The historical data trend for Coherus BioSciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coherus BioSciences Days Payable Chart

Coherus BioSciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

437.31

211.50

95.95

69.46

54.05

Coherus BioSciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															91.99	39.45	96.82	184.54	222.40

Competitive Comparison of Coherus BioSciences's Days Payable

For the Biotechnology subindustry, Coherus BioSciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coherus BioSciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coherus BioSciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Coherus BioSciences's Days Payable falls into.

Coherus BioSciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Coherus BioSciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (10.881	+	32.296)	/	2 )	/	145.796	*	365
=	21.5885					/	145.796	*	365
=	54.05

Coherus BioSciences's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (71.364	+	19.726)	/	2 )	/	18.687	*	365 / 4
=	45.545					/	18.687	*	365 / 4
=	222.40

Coherus BioSciences Days Payable Related Terms

Thank you for viewing the detailed overview of Coherus BioSciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Coherus BioSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coherus BioSciences Inc (FRA:8C5) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

CHRS:USA

Address

333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065

Website

https://www.coherus.com

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.

Coherus BioSciences Headlines

No Headlines